Qube Research & Technologies LTD Infinity Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.59 - $1.7 $5,042 - $14,529	-8,547 Reduced 10.43%	73,421 $87,000
Q2 2022 Aug 15, 2022	BUY	$0.49 - $1.2 $40,164 - $98,361	81,968 New	81,968 $52,000
Q3 2021 Nov 12, 2021	SELL	$1.52 - $3.82 $40,232 - $101,111	-26,469 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.66 - $3.47 $70,407 - $91,847	26,469 New	26,469 $79,000
Q1 2021 May 14, 2021	SELL	$1.98 - $5.36 $57,592 - $155,906	-29,087 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$1.05 - $2.77 $96,370 - $254,233	-91,781 Reduced 75.93%	29,087 $62,000
Q3 2020 Nov 12, 2020	BUY	$0.82 - $1.34 $78,605 - $128,452	95,860 Added 383.32%	120,868 $141,000
Q2 2020 Aug 14, 2020	BUY	$0.77 - $1.13 $19,256 - $28,259	25,008 New	25,008 $23,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.